Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (920)	8/17/1999 10:07:00 AM
From: dalroi	Read Replies (1) \| Respond to of 2001

rick i secund your motion valuation of glia is realy ridiculous even a beginning biotech investor like me can see that if i see what others are getting as value Innogenetics a belgian firm is now quoted 22 euro commig from top of 70 euro they only make losses, sales of lipa test kits are afetr the abbot murex deal almost nill UCB is now at 40 euro and more then 25% of their sales are coming from zyrtec which expires shortly and is surpassed by SEPR so i could go on. PS do you rate NBIX a buy to the HARMON standart ? greetings from belgium